The DOI matches its Crossref record.
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.
Abstract
BACKGROUND: Left ventricular enlargement after myocardial infarction increases the likelihood of an adverse outcome. In an echocardiographic substudy of the Survival and Ventricular Enlargement (SAVE) Trial, we assessed whether captopril would attenuate progressive left ventricular enlargement in patients with left ventricular dysfunction after acute myocardial infarction and, if so, whether this would be associated with improved clinical outcome. METHODS AND RESULTS: Two-dimensional transthoracic echocardiograms were obtained in 512 patients at a mean of 11.1 +/- 3.2 days after infarction and were repeated at 1 year in 420 survivors. Left ventricular size was assessed as left ventricular cavity areas at end diastole and end systole and left ventricular function as percent change in cavity area from end diastole to end systole. Patients were randomly assigned to placebo or captopril, and the incidence of adverse cardiovascular events consisting of cardiovascular death, heart failure requiring either hospitalization or open-label angiotensin-converting enzyme inhibitor therapy, and recurrent infarction were determined over a follow-up period averaging 3.0 +/- 0.6 years. Irrespective of treatment assignment, baseline left ventricular systolic area and percent change in area were strong predictors of cardiovascular mortality and adverse cardiovascular events. At 1 year, left ventricular end-diastolic and end-systolic areas were larger in the placebo than in the captopril group (P = .038, P = .015, respectively), and percent change in cavity area was greater in the captopril group (P = .005). One hundred eleven of the 420 1-year survivors with 1-year echo measurements (26.4%) experienced a major adverse cardiovascular event, and these patients had more than a threefold greater increase in left ventricular cavity areas than those with an uncomplicated course. Sixty-nine patients with adverse cardiovascular events were in the placebo group compared with 42 patients in the captopril-treated group (a risk reduction of 35%, P = .010). CONCLUSIONS: Two-dimensional echocardiography provides important and independent prognostic information in patients after infarction. Left ventricular enlargement and function after infarction are associated with the development of adverse cardiac events. Attenuation of ventricular enlargement with captopril in these patients was associated with a reduction in adverse events. This study demonstrates the linkage between attenuation of left ventricular enlargement by captopril after infarction and improved clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Authors/Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,829
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
(2015) · Europace · doi:10.1093/europace/euv319 · Cited by 1,592
Grigioni, F., Enriquez-Sarano, M., Zehr, K. J., Bailey, K. R., & Tajik, A. J. (2001) · Circulation · doi:10.1161/01.cir.103.13.1759 · Cited by 1,429
Wu, K. C., Zerhouni, E. A., Judd, R. M., Lugo-Olivieri, C. H., Barouch, L. A., Schulman, S. P., Blumenthal, R. S., & Lima, J. A. C. (1998) · Circulation · doi:10.1161/01.cir.97.8.765 · Cited by 1,357
Lindahl, B., Toss, H., Siegbahn, A., Venge, P., & Wallentin, L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431602 · Cited by 1,224
St John Sutton, M. G., Plappert, T., Abraham, W. T., Smith, A. L., DeLurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Fisher, W. G., Ellestad, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065226.24159.e9 · Cited by 1,124
Self-citationThe role of TGF-β signaling in myocardial infarction and cardiac remodeling
BUJAK, M., & FRANGOGIANNIS, N. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.002 · Cited by 927
American Society of Echocardiography recommendations for use of echocardiography in clinical trials
Gottdiener, J. S., Bednarz, J., Devereux, R., Gardin, J., Klein, A., Manning, W. J., Morehead, A., Kitzman, D., Oh, J., Quinones, M., et al. (2004) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2004.07.013 · Cited by 902
Mechanisms and Models in Heart Failure: The Biomechanical Model and Beyond
Mann, D. L., & Bristow, M. R. (2005) · Circulation · doi:10.1161/circulationaha.104.500546 · Cited by 867
Mechanisms and Models in Heart Failure: A Combinatorial Approach
Mann, D. L. (1999) · Circulation · doi:10.1161/01.cir.100.9.999 · Cited by 773
Left Ventricular Remodeling in Heart Failure
Konstam, M. A., Kramer, D. G., Patel, A. R., Maron, M. S., & Udelson, J. E. (2011) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2010.10.008 · Cited by 765
Yu, C.-M., Bleeker, G. B., Fung, J. W.-H., Schalij, M. J., Zhang, Q., van der Wall, E. E., Chan, Y.-S., Kong, S.-L., & Bax, J. J. (2005) · Circulation · doi:10.1161/circulationaha.105.538272 · Cited by 705
Omland, T., Aakvaag, A., Bonarjee, V. V. S., Caidahl, K., Lie, R. T., Nilsen, D. W. T., Sundsfjord, J. A., & Dickstein, K. (1996) · Circulation · doi:10.1161/01.cir.93.11.1963 · Cited by 700
Yazaki, Y., Isobe, M., Hiroe, M., Morimoto, S.-I., Hiramitsu, S., Nakano, T., Izumi, T., & Sekiguchi, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01978-6 · Cited by 664
Pedersen, O. D., Bagger, H., Køber, L., & Torp-Pedersen, C. (1999) · Circulation · doi:10.1161/01.cir.100.4.376 · Cited by 656
The immune system and cardiac repair
FRANGOGIANNIS, N. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.06.007 · Cited by 641
Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure
Kumarswamy, R., Bauters, C., Volkmann, I., Maury, F., Fetisch, J., Holzmann, A., Lemesle, G., de Groote, P., Pinet, F., & Thum, T. (2014) · Circulation Research · doi:10.1161/circresaha.114.303915 · Cited by 625
Bolognese, L., Neskovic, A. N., Parodi, G., Cerisano, G., Buonamici, P., Santoro, G. M., & Antoniucci, D. (2002) · Circulation · doi:10.1161/01.cir.0000036014.90197.fa · Cited by 601
Vermes, E., Tardif, J.-C., Bourassa, M. G., Racine, N., Levesque, S., White, M., Guerra, P. G., & Ducharme, A. (2003) · Circulation · doi:10.1161/01.cir.0000072793.81076.d4 · Cited by 578
Schocken, D. D., Benjamin, E. J., Fonarow, G. C., Krumholz, H. M., Levy, D., Mensah, G. A., Narula, J., Shor, E. S., Young, J. B., & Hong, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.188965 · Cited by 552
Aurigemma, G. P., Gottdiener, J. S., Shemanski, L., Gardin, J., & Kitzman, D. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01110-x · Cited by 531
Ammar, K. A., Jacobsen, S. J., Mahoney, D. W., Kors, J. A., Redfield, M. M., Burnett, J. C., & Rodeheffer, R. J. (2007) · Circulation · doi:10.1161/circulationaha.106.666818 · Cited by 522
Li, Q., Li, B., Wang, X., Leri, A., Jana, K. P., Liu, Y., Kajstura, J., Baserga, R., & Anversa, P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119730 · Cited by 500
Sutton, M. S. J., Pfeffer, M. A., Moye, L., Plappert, T., Rouleau, J. L., Lamas, G., Rouleau, J., Parker, J. O., Arnold, M. O., Sussex, B., et al. (1997) · Circulation · doi:10.1161/01.cir.96.10.3294 · Cited by 484
Self-citationRight ventricular dysfunction and risk of heart failure and mortality after myocardial infarction
Zornoff, L. A. M., Skali, H., Pfeffer, M. A., St. John Sutton, M., Rouleau, J. L., Lamas, G. A., Plappert, T., Rouleau, J. R., Moyé, L. A., Lewis, S. J., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01804-1 · Cited by 473
Self-citationIbánez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2017) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2017.11.010 · Cited by 461
Doughty, R. N., Whalley, G. A., Gamble, G., MacMahon, S., & Sharpe, N. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00012-0 · Cited by 422
Abbate, A., Kontos, M. C., Grizzard, J. D., Biondi-Zoccai, G. G. L., Van Tassell, B. W., Robati, R., Roach, L. M., Arena, R. A., Roberts, C. S., Varma, A., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.059 · Cited by 415
Stellbrink, C., Breithardt, O.-A., Franke, A., Sack, S., Bakker, P., Auricchio, A., Pochet, T., Salo, R., Kramer, A., & Spinelli, J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01637-0 · Cited by 410
Vasan, R. S., Larson, M. G., Benjamin, E. J., Evans, J. C., & Levy, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705083361903 · Cited by 402
Abbate, A., Van Tassell, B. W., Biondi-Zoccai, G., Kontos, M. C., Grizzard, J. D., Spillman, D. W., Oddi, C., Roberts, C. S., Melchior, R. D., Mueller, G. H., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.287 · Cited by 393
Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling
Bujak, M., Dobaczewski, M., Chatila, K., Mendoza, L. H., Li, N., Reddy, A., & Frangogiannis, N. G. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070974 · Cited by 365
Schulman, S. P., Becker, L. C., Kass, D. A., Champion, H. C., Terrin, M. L., Forman, S., Ernst, K. V., Kelemen, M. D., Townsend, S. N., Capriotti, A., et al. (2006) · JAMA · doi:10.1001/jama.295.1.58 · Cited by 357
The Management of Chronic Heart Failure
Cohn, J. N. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350707 · Cited by 330
Doughty, R. N., Whalley, G. A., Walsh, H. A., Gamble, G. D., López-Sendón, J., & Sharpe, N. (2004) · Circulation · doi:10.1161/01.cir.0000108928.25690.94 · Cited by 328
The role of IL-1 in the pathogenesis of heart disease
Bujak, M., & Frangogiannis, N. G. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0024-y · Cited by 307
Tardif, J.-C., O'Meara, E., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Tavazzi, L., & Swedberg, K. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr311 · Cited by 300
Solomon, S. D., Skali, H., Anavekar, N. S., Bourgoun, M., Barvik, S., Ghali, J. K., Warnica, J. W., Khrakovskaya, M., Arnold, J. M. O., Schwartz, Y., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.508093 · Cited by 298
Self-citationStructural Basis for Heart Failure: Ventricular Remodeling and Its Pharmacological Inhibition
Cohn, J. N. (1995) · Circulation · doi:10.1161/01.cir.91.10.2504 · Cited by 297
The Mechanistic Basis of Infarct Healing
Frangogiannis, N. G. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1907 · Cited by 288
Magnetic Resonance Imaging Determination of Cardiac Prognosis
Hundley, W. G., Morgan, T. M., Neagle, C. M., Hamilton, C. A., Rerkpattanapipat, P., & Link, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000036017.46437.02 · Cited by 278
Quiñones, M. A., Greenberg, B. H., Kopelen, H. A., Koilpillai, C., Limacher, M. C., Shindler, D. M., Shelton, B. J., & Weiner, D. H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00511-8 · Cited by 276
Vantrimpont, P., Rouleau, J. L., Wun, C.-C., Ciampi, A., Klein, M., Sussex, B., Arnold, J. M. O., Moyé, L., & Pfeffer, M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00489-5 · Cited by 274
Self-citationDuan, Q., McMahon, S., Anand, P., Shah, H., Thomas, S., Salunga, H. T., Huang, Y., Zhang, R., Sahadevan, A., Lemieux, M. E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5084 · Cited by 262
Small Animal Models of Heart Failure: Development of Novel Therapies, Past and Present
Patten, R. D., & Hall-Porter, M. R. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.839761 · Cited by 261
High-risk drugs in the elderly population
Demaagd, G. (1995) · Geriatric Nursing · doi:10.1016/s0197-4572(05)80161-2 · Cited by 9
Metadata
- Authors
- St John Sutton, M., Pfeffer, M. A., Plappert, T., Rouleau, J. L., Moyé, L. A., Dagenais, G. R., Lamas, G. A., Klein, M., Sussex, B., & Goldman, S.
- Venue
- Circulation
- Published
- 1994-01
- Volume
- 89
- Issue
- 1
- Pages
- 68-75
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2004114486
- Cited by
- 823
- References
- 0
- FWCI
- 26.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.